Please note the ANZCTR will be unattended from Friday 24 December 2021 for the holidays. The Registry will re-open on Monday 17 January 2022. Submissions and updates will not be processed during that time.

For new and updated trial submissions, we are processing trials as quickly as possible and appreciate your patience. We recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from

For full trial details, please see the original record at

Registration number
Ethics application status
Date submitted
Date registered
Date last updated

Titles & IDs
Public title
Patient INformation About Options for Treatment - PINOT
Scientific title
Patient Information About Options for Treatment of Stage 5 Chronic Kidney Disease
Secondary ID [1] 0 0
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Chronic Kidney Disease 0 0
Condition category
Condition code
Renal and Urogenital 0 0 0 0
Kidney disease
Renal and Urogenital 0 0 0 0
Other renal and urogenital disorders

Study type
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Stage 5 chronic kidney disease - Incident patients commencing renal replacement therapy or conservative care

Comparator / control treatment
Control group

Primary outcome [1] 0 0
Proportion of incident Stage 5 CKD patients who receive information about their treatment options prior to commencing treatment
Timepoint [1] 0 0
Time prior to commencement of treatment. eg. 3 months
Secondary outcome [1] 0 0
Stage of CKD (based on eGFR) when information about treatment options is first given
Timepoint [1] 0 0
one time point prior to commencement of treatment
Secondary outcome [2] 0 0
Patient and unit characteristics associated with commencing renal replacement therapy versus conservative care
Timepoint [2] 0 0
One time point based on commencement date of first treatment

Key inclusion criteria
- Patients attending Australian adult or pediatric renal units

- Patients with Stage 5 chronic kidney disease commencing dialysis or having a
pre-emptive transplant or with decision made for conservative care and eGFR <
15ml/min/1.73m2 between 1st July and 30th September 2009
Minimum age
No limit
Maximum age
No limit
Both males and females
Can healthy volunteers participate?
Key exclusion criteria
- Patients with acute kidney injury not requiring chronic renal replacement therapy

- Patients with a failing kidney transplant returning to dialysis

Study design
Statistical methods / analysis

Recruitment status
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Date of last participant enrolment
Date of last data collection
Sample size
Accrual to date
Recruitment in Australia
Recruitment state(s)
Recruitment hospital [1] 0 0
University of Sydney - Sydney
Recruitment postcode(s) [1] 0 0
2006 - Sydney

Funding & Sponsors
Primary sponsor type
University of Sydney
Other collaborator category [1] 0 0
Name [1] 0 0
National Health and Medical Research Council, Australia
Address [1] 0 0
Country [1] 0 0
Other collaborator category [2] 0 0
Name [2] 0 0
Sydney South West Area Health Service
Address [2] 0 0
Country [2] 0 0
Other collaborator category [3] 0 0
Name [3] 0 0
South West Sydney Local Health District
Address [3] 0 0
Country [3] 0 0

Ethics approval
Ethics application status

Brief summary
This prospective observational study is designed to find out what treatment options new
patients with chronic kidney disease learn about from their renal unit.

Aims: To determine the proportion of new CKD patients who receive information about treatment
options prior to commencing dialysis, pre-emptive transplantation or conservative management.
To determine the timing (i.e. patient's stage of disease) when information is given. To find
out whether patients have a friend or family member with them when information is given.

Research Design and methods: This study is an assessment of CKD education practices.
Nephrologists and pre-dialysis coordinators from each renal unit will complete questionnaires
about information that was given to each new dialysis, pre-emptive transplant or
conservatively managed patient that started treatment during a 3 month period.

Study hypothesis: Approximately one third of CKD patients will receive information after
starting treatment. There will be a positive association between in-centre haemodialysis and
later referral, non-English speaking background, and advancing age. Significance: The results
from this national audit will provide Australian nephrologists and renal nurses with evidence
about CKD education practices and compliance with clinical practice guidelines. The results
may highlight opportunities for improvement in practice.
Trial website
Trial related presentations / publications
Morton RL, Howard K, Webster AC, Snelling P. Patient information about options for treatment: Methods of a national audit of information provision in chronic kidney disease. Nephrology (Carlton). 2010 Sep;15(6):649-52.
Public notes

Principal investigator
Name 0 0
Kirsten Howard, PhD
Address 0 0
University of Sydney
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

Summary results
Other publications